ViaMune Inc.

ViaMune is a preclinical-stage company and offers a fully synthetic vaccine platform that generates robust immune responses to tumor-specific targets. ViaMunes patented technology provides a unique path to targeting structures found only on tumor cells.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://viamune.com
Founded2011
Disease Focus
Development Stage
STOCK CODENon Listed
Address
111 Riverbend Rd, 30602
Athens
United States
Email
Contact Number
+1 706-372-4261

ViaMune is a preclinical-stage company and offers a fully synthetic vaccine platform that generates robust immune responses to tumor-specific targets. ViaMunes patented technology provides a unique path to targeting structures found only on tumor cells.

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”” connections=”true” suffix=””]